The Centenary Institute’s Dr Stefan Oehlers (Immune-vascular Interactions Laboratory within the Tuberculosis Research Program), Dr Jessamy Tiffen (Melanoma Oncology and Immunology Program) and Dr Hui Emma Zhang (Liver Enzymes in Metabolism and Inflammation Program) have all been named on the Educator’s list of Higher Education Rising Stars for 2020.
The list showcases individuals across the higher education spectrum who are making waves in the early stages of their careers and who have demonstrated leadership, innovation and achievement in their career to date.
Read more by clicking the link here:
Pictured: Dr Hui Emma Zhang, Professor Mark Gorrell and Dr Avik Majumdar
Collaborative research between the Centenary Institute and Royal Prince Alfred Hospital has been recognised with a prestigious award.
Dr Avik Majumdar, a staff specialist transplant hepatologist at RPA Hospital, is among six recipients of the 2019 Gilead Australia Fellowship Program, which awarded a total of $250,000 for these six research projects.
Dr Majumdar has been collaborating with several Centenary researchers on the project, including Head of the Liver Enzymes in Metabolism and Inflammation Program Professor Mark Gorrell, Head of the Liver injury and Cancer Program Professor Geoff McCaughan, and Dr Hui Emma Zhang.
The group is working to validate an alternative test for people with non-alcoholic fatty liver disease (NAFLD), to understand whether a patient is at risk of developing more severe disease, and requires further treatment.
Congratulations Dr Majumdar and your collaborators at Centenary on this significant achievement!
Learn more about Centenary’s Liver Enzymes in Metabolism and Inflammation and Liver Injury and Cancer Programs.
Read about how Dr Hui Emma Zhang led a recent study, which discovered dozens of new likely targets for particular enzyme (FAP) that is within most tumours.
Pictured: Dr Jacob Qi, Dr Renjing Liu and Professor Phil Hansbro.
The Centenary Institute would like to congratulate four of our researchers on securing funding under the Federal Government’s highly-competitive National Health and Medical Research Council’s (NHMRC) scheme.
Professor Phil Hansbro, Head of Centenary’s Centre for Inflammation, has been awarded a four-year Project Grant. His team will use the funding to develop new therapies for chronic obstructive pulmonary disease (COPD) – the third leading cause of death worldwide.
Dr Renjing Liu, Head of the Agnes Ginges Laboratory for Diseases of the Aorta in Centenary’s Vascular Biology Program, has been awarded two NHMRC project grants starting in 2019 to explore the role of epigenetics in cardiovascular diseases.
“Collaboration is key to successful research. The funding from NHMRC will allow me to continue my collaborations with leading researchers both nationally and abroad because improving human health is a global effort. It will also allow me to build a strong team to see that our work will contribute to increased understanding of biology and diseases, and add to making a difference in people’s lives,” says Dr Liu.
Dr Jacob Qi, also from Centenary’s Vascular Biology Program, has been awarded a three-year grant, which he will use to bolster his research into discovering the metabolic basis of non-alcoholic fatty liver disease progression to liver disease.
Dr Gerard Chu from Centenary’s Gene and Stem Cell Therapy Program, has been awarded a three-year Postgraduate Scholarship grant. Dr Chu’s research is focused on analysing the immune response and optimising the effectiveness of Mesothelin CAR T-Cell therapy in cancer.
Earlier this year, Centenary’s Professor Chris Semsarian, Associate Professor Jodie Ingles and Professor Warwick Britton were also awarded funding from the NHMRC. Read more about those grants here.